Back
Lineage Cell Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
42
LCTX
Lineage Cell Therapeutics
Last Price:
$0.47
Seasonality Move:
-3.44%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and LCTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lineage Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.46 | Buy |
| 20-day SMA: | 0.46 | Buy |
| 50-day SMA: | 0.47 | Buy |
| 200-day SMA: | 0.69 | Sell |
| 8-day EMA: | 0.46 | Buy |
| 20-day EMA: | 0.46 | Buy |
| 50-day EMA: | 0.49 | Sell |
| 200-day EMA: | 0.67 | Sell |
Lineage Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.98 | Buy |
| Chaikin Money Flow: | 512346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.43 - 0.49) | Buy |
| Bollinger Bands (100): | (0.44 - 0.62) | Sell |
Lineage Cell Therapeutics Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics Stock
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.47 while LCTX 8-day simple moving average is 0.46, which is a Buy signal.
-
The stock price of LCTX is 0.47 while Lineage Cell Therapeutics 20-day SMA is 0.46, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day simple moving average is 0.47 while LCTX share price is 0.47, making it a Buy technically.
-
LCTX stock price is 0.47 and Lineage Cell Therapeutics 200-day simple moving average is 0.69, creating a Sell signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
42
Lineage Cell Therapeutics (LCTX)
is a Sell
Is Lineage Cell Therapeutics a Buy or a Sell?
-
Lineage Cell Therapeutics stock is rated a SellThe current Lineage Cell Therapeutics [LCTX] share price is $0.47. The Score for LCTX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics Stock Info
Market Cap:
107.4M
Price in USD:
0.47
Share Volume:
565.2K
Lineage Cell Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.37
Sell
42
Lineage Cell Therapeutics (LCTX)
is a Sell
Lineage Cell Therapeutics Share Price Forecast
-
What is the Lineage Cell Therapeutics stock price today?The Lineage Cell Therapeutics stock price is 0.47 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics is overvalued.
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.47 while LCTX 8-day exponential moving average is 0.46, which is a Buy signal.
-
The stock price of LCTX is 0.47 while Lineage Cell Therapeutics 20-day EMA is 0.46, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day exponential moving average is 0.49 while LCTX share price is 0.47, making it a Sell technically.
-
LCTX stock price is 0.47 and Lineage Cell Therapeutics 200-day simple moving average is 0.67, creating a Sell signal.
Fundamental Analysis of Lineage Cell Therapeutics
Is Lineage Cell Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.00 per share, and an increase next year of $0.04 per share.
Technical Analysis of Lineage Cell Therapeutics
Should I short Lineage Cell Therapeutics stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Lineage Cell Therapeutics is a Sell
-
Lineage Cell Therapeutics Relative Strength Index (RSI) is 50.98, which suggest Lineage Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Lineage Cell Therapeutics is (0.43 - 0.49), which suggest Lineage Cell Therapeutics is a Sell
-
The Bollinger Bands (100) for Lineage Cell Therapeutics is (0.44 - 0.62), which suggest Lineage Cell Therapeutics is a Sell
* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.